Log In

Term Description

Qualitative detection of SARS coronavirus 2 (SARS-CoV-2) in various specimens, including lower & upper respiratory, serum, stool or urine, by nucleic acid amplification with probe-based detection. Results may be based on multiple assays to determine the presence of the virus in a specimen.

Part Description

LP417540-4   SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. PMID: 31953166 Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.

The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus. Source: LOINC

Reference Information

TypeSourceReference
Package InsertCenters for Disease Control and PreventionThis document describes the use of real-time RT PCR (rRT-PCR) assays for the in vitro qualitative detection of 2019-Novel Coronavirus (2019-nCoV) in respiratory specimens and sera. The 2019-nCoV primer and probe sets are designed for the universal detection of SARS-like coronaviruses (N3 assay) and for specific detection of 2019-nCoV (N1 and N2 assays). Real-Time RT-PCR Panel for Detection 2019-Novel Coronavirus

LOINC Names Get Info

Fully-Specified Name
SARS coronavirus 2 RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar
Long Common Name
SARS-CoV-2 (COVID-19) RNA [Presence] in Specimen by NAA with probe detection
Short Name
SARS-CoV-2 RNA Spec Ql NAA+probe
Display Name
SARS-CoV-2 (COVID-19) RNA NAA+probe Ql (Specimen)
Consumer Name Alpha Get Info
SARS-CoV-2 (COVID-19), Specimen

Part Model Get Info

  • Component
    SARS coronavirus 2 RNA
    LP417541-2
    • Analyte
      SARS coronavirus 2 RNA
      LP417541-2
      • Component Numerator
        SARS coronavirus 2 RNA
        LP417541-2
        • Component Numerator Core
          SARS coronavirus 2
          LP417540-4
        • Component Numerator Core Suffix
          RNA
          LP32423-3
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    PrThr
    LP217195-9
  • Time
    Pt
    LP6960-1
  • System
    XXX
    LP7735-6
    • System Core
      XXX
      LP7735-6
    • Super System
      NULL
       
  • Scale
    Ord
    LP7751-3
  • Method
    Probe.amp.tar
    LP6464-4

Ask at Order Entry

81959-9 Public health laboratory ask at order entry panel

This panel contains a convenience grouping of terms for questions commonly asked when an order is placed in a public health laboratory.

LOINCNameR/O/CCardinalityExample UCUM Units
81959-9Public health laboratory ask at order entry panel
Indent81744-5Submitter's laboratory test method [Type] in Specimen
Indent81658-7Suspected organism [Identifier] in Specimen
Indent86952-9Preliminary testing done Specimen
Indent86953-7Preliminary testing result Specimen
Indent86955-2Preliminary testing affected submission for further testing Specimen
Indent95417-2Whether this is the patient's first test for condition of interest
Indent95418-0Whether patient is employed in a healthcare setting
Indent95419-8Whether the patient has symptoms related to condition of interest
Indent11368-8Illness or injury onset date and timeC
Indent77974-4Whether the patient was hospitalized for condition of interest
Indent95420-6Whether the patient was admitted to intensive care unit (ICU) for condition of interest
Indent95421-4Whether patient resides in a congregate care setting
Indent82810-3Pregnancy statusC
Indent30525-0Agea

Example Answer List: LL3250-9

Source: Association of Public Health Laboratories
AnswerCodeScoreAnswer ID
DetectedLA11882-0
Not detectedLA11883-8
InconclusiveCopyright http://snomed.info/sct ID:419984006 Inconclusive (qualifier value)LA9663-1
Specimen unsatisfactory for evaluationCopyright http://snomed.info/sct ID:125154007 Specimen unsatisfactory for evaluation (finding)LA13548-5

Basic Attributes

Class
MICRO
Type
Laboratory
First Released
Version 2.68
Last Updated
Version 2.73 (MIN)
Order vs. Observation
Both
Common Test Rank Get Info
2296

Member of these Panels

LOINCLong Common Name
94306-8SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection

Member of these Groups Get Info

LOINC GroupGroup Name
LG51017-8SARSCoV2 detection
LG51019-4SARSCoV2 molecular detection

Language Variants Get Info

TagLanguageTranslation
cs-CZCzech (Czechia)SARS-CoV-2 (COVID-19) RNA:Přítomnost nebo práh:Časový bod:XXX:Ordinální:Amplifikace nukleových kyselin s detekcí sondou
de-ATGerman (Austria)Synonyms: SARS-CoV-2-RNA ql. /Material n. spez. PCR
de-DEGerman (Germany)SARS-Coronavirus 2 RNA:Nachweis oder Schwellenwert:Zeitpunkt:XXX:Ordinal:Zielfragmentamplifikation mit Sondendetektion
el-GRGreek (Greece)Κορωνοϊός SARS 2 RNA:PrThr:Pt:XXX:Ord:Ανιχνευτής.ενίσχυση.στόχου
Synonyms: MICRO Ord PrThr Pt RNA XXX Ανιχνευτής Ανιχνευτής.ενίσχυση Ανιχνευτής.ενίσχυση.στόχου Κορωνοϊός Κορωνοϊός SARS Κορωνοϊός SARS 2
es-ESSpanish (Spain)Panel del SARS-CoV-2 (COVID-19) RNA:PrThr:Punto temporal:XXX:Ord:Sonda con amplificación dirigida
es-MXSpanish (Mexico)ARN del coronavirus 2 del SARS:Presencia o umbral:Punto temporal:XXX:Ordinal:Amplificación de ácidos nucleicos con detección de sonda
fr-FRFrench (France)Coronavirus SARS-CoV-2 ARN:Présence/Seuil:Ponctuel:Milieux divers:Qualitatif:PCR amplification de cible
fr-CAFrench (Canada)coronavirus 2 du SRAS ARN:Présence-Seuil:Temps ponctuel:XXX:Ordinal:Sonde avec amplification de la cible
it-ITItalian (Italy)SARS coronavirus 2 RNA:PrThr:Pt:XXX:Ord:Sonda.amp.tar
Synonyms: Coronavirus della SARS Microbiologia Presenza o Soglia Punto nel tempo (episodio) SARS-CoV-2 (COVID-19) Sonda con amplificazione Sonda con amplificazione del target Sonda di DNA
nl-NLDutch (Netherlands)SARS-CoV-2 RNA:aanwezigheid:moment:XXX:ordinaal:probe-detectie
Synonyms: probe.amp.tar SARS-virus severe acute respiratory syndrome coronavirus 2; 2019-nCoV; 2019 novel coronavirus; COVID-19
pl-PLPolish (Poland)SARS-CoV-2 RNA:granica wykrywalności:punkt w czasie:XXX:uporządkowany:sonda.amplifikacja.cel
Synonyms: amplifikacja kwasu nukleinowego z detekcją za pomocą sondy amplifikacja z detekcją za pomocą sondy Koronawirus
zh-CNChinese (China)SARS 冠状病毒 2 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向
Synonyms: 2019 新型冠状病毒;2019 年新型冠状病毒;2019-nCoV;SARS-CoV-2;新型冠状病毒肺炎;新冠肺炎;Coronavirus disease 2019;COVID-19;冠状病毒疾病2019;严重急性呼吸综合征;severe acute respiratory syndrome;SARS;传染性非典型肺炎;infectious atypical pneumonia;非典 Ⅱ II SARS;SARS 病毒;SARS-CoV;严重急性呼吸综合征;严重急性呼吸综合征病毒;萨斯病毒;非典;非典型肺炎;非典型肺炎病毒;非典病毒 不明的;其他;将在相应消息内其他部分之中加以详细说明;未作详细说明的;未作说明的;未做说明的标本;未加规定的;未加说明的标本;杂项 依次型;分类顺序型;定性的;序数型（或称等级型）;性质上的;有序型;有序性分类应答;有序性分类结果;秩次型;等级型;筛查;顺序型 借助扩增的探针方法;借助扩增的探针法;探针法.扩增 借助靶向扩增的探针方法;借助靶向扩增的探针法;探针法.扩增.靶向 存在情况;存在;存在与否;是否存在;阈值;界值;界限;阀值;临界值;存在情况（存在、存在与否、是否存在）或阈值（界值、界限、阀值、临界值） 微生物学;微生物学试验;微生物学试验（培养、DNA、抗原及抗体） 扩增型 扩增性 时刻;随机;随意;瞬间 核糖核酸;Ribonucleic acid 经过扩增的 脱氧核糖核酸探针

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=94309-2